On May 27, MicroPort Robotics-B declined 5.02% in regular trading, trading at 26.36 HKD/share, with trading volume of approximately 61.60 million HKD.

On the news front, the decline was primarily triggered by significant institutional selling pressure. Equity change filings revealed that multiple entities under Hillhouse Capital substantially reduced their holdings, with individual entities offloading as many as 20.639 million shares each. Meanwhile, market concerns persisted over the possibility that parent company MicroPort Medical may sell robotics business equity to alleviate cash flow pressures, creating further valuation overhang.

At the sector level, the Health Care Equipment industry broadly weakened, amplifying downward pressure on individual stocks. Within the sector, MicroPort Medical fell 2.77%, LifeTech Scientific dropped 3.39%, Diagens-B declined 2.01%, and Angelalign slipped 0.57%. The company remains in a loss-making stage with a negative P/E ratio of approximately -101.86, and risk-averse sentiment among investors appears elevated against this high-valuation backdrop.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)